Showing 21-30 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Cooperative harmonization and validation of an islet-specific AIM assay Benaroya Research Institute at Virginia Mason Karen Cerosaletti Cures 01-February-2024 to 31-January-2026 $299,998.00
Early immune and beta cell monitoring predicts treatment response Benaroya Research Institute at Virginia Mason S. Alice Long Cures 01-August-2019 to 31-July-2025 $2,499,814.79
New lipid biomarker to predict early risk for Type 1 diabetes Beth Israel Deaconess Medical Center Inc Barbara Kahn Cures 01-September-2024 to 31-August-2027 $899,997.53
Integration of Slow-Release A1AT-loaded Nanoparticles for Enhanced Cell Therapy in Type 1 Diabetes Beth Israel Deaconess Medical Center Inc Giuseppe Pettinato Cures 01-October-2024 to 30-September-2025 $200,000.00
Determining the role of new genes that may be involved in Type 1 Diabetes Pathogenesis Beth Israel Deaconess Medical Center Inc Ismail Syed Cures 01-June-2024 to 31-October-2025 $199,999.67
Consulting Support for Continuity Biosciences Biologics Consulting Group, Inc. Diana Colleluori Cures 01-April-2025 to 31-August-2025 $63,475.00
Ad Hoc Consulting Support Biologics Consulting Group, Inc. Diana Colleluori Cures 01-July-2025 to 30-November-2025 $61,475.00
Engineered Nanobodies to Visualize and Direct Antigen-Specific Tolerance in T1D Boston Children's Hospital Novalia Pishesha Cures 01-March-2025 to 28-February-2030 $999,999.00
A wireless oxygen generating immune protection device to support long term cell transplantation for the treatment of Type I Diabetes Boston Children's Hospital Robert Langer Cures 01-August-2025 to 31-July-2028 $2,481,286.98
Understanding the role of scaffold microarchitecture on survival and function of stem cell-derived beta cells Brown University Tejal Desai Cures 01-October-2022 to 30-September-2025 $474,761.58